RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Kevin Harrington | Oncologist in Sutton - Doctify
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
RM Magazine - spring 2012 - The Royal Marsden
Scientific Advisory Board – PsiVac
Cancer: Scientists aim to double survival within a decade | The Independent
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
My final lifeline" | The Biomedical Scientist Magazine of the IBMS
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Professor Kevin Harrington - News, Articles etc. - European Pharmaceutical Review
Kevin Harrington | Oncologist in Sutton - Doctify
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Potential of immunotherapy in head and neck cancer | VJOncology
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Kevin Harrington (@kevhar6763) / Twitter
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
